Radiometer, a leading provider of acute care testing solutions, is helping to promote awareness of the importance of early diagnosis of sepsis, a global medical emergency affecting over 20 million people every year.
Symptoms are often unclear and unspecific, making diagnosis extremely challenging. As a result, the condition is often overlooked or recognized too late, with devastating consequences; 30 percent or more of patients who develop sepsis die.
Radiometer is highlighting the importance of identifying the condition and initiating appropriate antibiotic treatment at the earliest opportunity. Its broad portfolio of acute care tests provides healthcare professionals with vital tools to monitor key diagnostic and prognostic markers for sepsis, including glucose, bilirubin, lactate, white blood cells, Creactive protein, creatinine and blood gas. These tests are perfectly complemented by Radiometer’s recently launched procalcitonin (PCT) assay, enabling early and convenient measurement of PCT – the biomarker of choice to aid the diagnosis of sepsis – with results available to treating physicians in less than 21 minutes.
Rapid point-of-care testing significantly improves turnaround times, empowering clinicians to diagnose sepsis sooner, because the earlier sepsis is detected, the better the odds for a full recovery.